Sauerkraut contains anticancer compound

October 17, 2002

Baseball fans might want to add a little more sauerkraut to their hot dogs: Researchers have identified compounds in the tangy topping, made from fermented cabbage, that may fight cancer. Their study will appear in the Oct. 23 print issue of the Journal of Agricultural and Food Chemistry, a peer-reviewed journal of the American Chemical Society, the world's largest scientific society.

The researchers found that the process of fermenting cabbage produces isothiocyanates, a class of compounds that have been identified in previous studies as potential cancer-fighting agents. In animal studies, the compounds appear to prevent the growth of cancer, particularly in the breast, colon, lung and liver, they say. No one knows yet whether the compounds, which are not found in raw cabbage, have a similar effect in humans. Further studies are needed, they add.

"We are finding that fermented cabbage could be healthier than raw or cooked cabbage, especially for fighting cancer," says Eeva-Liisa Ryhanen, Ph.D., research manager of MTT Agrifood Research Finland, located in Jokioinen, Finland. "We are now working on ways of optimizing the fermentation process to make it even healthier so that consumers will eat more [sauerkraut]."

In the current study, the researchers analyzed a variety of biologically active compounds in sauerkraut. Their samples were derived from white cabbage that was fermented.

Although raw cabbage is normally rich in a compound called glucosinolate, the researchers found that during the fermentation process enzymes are released that completely decompose the compound into several breakdown products. The majority of these products are cancer-fighting isothiocyanates.

Evidence for sauerkraut's anticancer effect is growing. Previous epidemiological studies have reported that Polish women who move to the United States have a higher incidence of breast cancer than those who remain in Poland, a statistic that some scientists attribute to a higher consumption of cabbage among the Polish women compared to their American counterparts.

At least one study found evidence that compounds in sauerkraut could inhibit estrogen, a hormone that can trigger the spread of breast cancer. The specific compounds have not been identified, however.

Currently, the researchers are investigating the effect of different starter cultures on the breakdown of glucosinolate. They hope the research may lead to sauerkraut with a greater abundance of healthy compounds, boosting its status as a functional (nutritious) food.

Besides anticancer compounds, the fermentation process also produces other healthy compounds not found in raw cabbage. These include organic acids such as lactic acid, which makes cabbage easier to digest. Although some loss in nutrients may occur during fermentation, sauerkraut is still a good source for vitamin C, certain minerals and dietary fiber, the researchers say.

Their work also adds to a growing number of studies demonstrating that similar cruciferous vegetables (including broccoli, cauliflower and Brussels sprouts) contain anticancer compounds.

Sauerkraut is a low-calorie, low-fat food that is second only to mustard as this country's favorite hot dog topping. Americans annually consume an estimated 387 million pounds of sauerkraut, or about 1.5 pounds per person yearly, according to Pickle Packers International, Inc., a trade association for the pickled vegetable industry.
-end-
Funding for this study was provided by Finland's Ministry of Agriculture and Forestry.

The online version of the research paper cited above was initially published Oct. 9 on the journal's Web site. Journalists can arrange access to this site by sending an e-mail to newsroom@acs.org or calling the contact person for this release.

American Chemical Society

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.